Vir Biotechnology (VIR) Restructuring Costs (2023 - 2025)

Vir Biotechnology (VIR) has 3 years of Restructuring Costs data on file, last reported at -$172000.0 in Q2 2025.

• For the quarter ending Q2 2025, Restructuring Costs fell 100.65% year-over-year to -$172000.0; the trailing twelve-month figure through Mar 2026 stood at -$172000.0 (down 100.49% YoY), and the FY2025 full-year result was -$182000.0, down 100.52% from the prior year.
• Restructuring Costs slipped to -$172000.0 in Q2 2025, from -$10000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $26.3 million in Q2 2024 to a low of -$3.9 million in Q4 2024.
• A 3-year average of $5.4 million and a median of $3.4 million in 2023 frame the typical range for Restructuring Costs.
• Peak annual rise in Restructuring Costs reached 389.66% in 2024, while the deepest fall reached 181.81% in 2024.
• Tracing VIR's Restructuring Costs over 3 years: stood at $4.8 million in 2023, then slumped by 181.81% to -$3.9 million in 2024, then soared by 95.64% to -$172000.0 in 2025.
• Business Quant data shows VIR's Restructuring Costs at -$172000.0 in Q2 2025, -$10000.0 in Q1 2025, and -$3.9 million in Q4 2024.